课题基金 / 基金详情

MEMBRANE PEPTIDE STRUCTURE VIA NMR & QUANTUM CHEMISTRY

MEMBRANE PEPTIDE STRUCTURE VIA NMR & QUANTUM CHEMISTRY
通过 NMR 观察膜肽结构
批准号:
6309034
负责人:
Eric Oldfield
金额:
$2.74万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-01 至 2002-01-14

项目摘要

项目成果

Eric Oldfield的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The SIR provided L-[2- 13 C]Tryptophan; 2g L-13- 13C]Tryptophan; 1.25g The idea behind this project is to make 13C-labeled gramicidins, as prototypical membrane penetrating peptide/protein fragments, and to explore their structure using the ISOTROPIC CARBON- 13 CHEMICAL SHIF'F, plus quantum chemistry, as a probe of structure. Previous work has always focused on orientational (15N, 2H, some 13C) information - the position of a line in an oriented sample, rather than completely analyzing chemical shifts using quantum chemistry, which is what we propose here. The ability to analyze isotropic chemical shifts in proteins in structural terms has a good chance of making may more systems amenable to investigation, and Ca, Cb, Cg of Trp in gramicidin should be excellent probes (especially since the Trps are functionally significant). By combining the observed isotropic chemical shifts with the quantum chemically computed shielding surfaces, one obtains for Trp the solutions for c 1, c2 as well as f, y, c 1 results for Val, Leu. These unique solutions remove problems associated with may dipolar or quadrupolar derived geometry restraints, ans when combined with the often more accurate (but multivalued) tensor data should yield very accurate, unique NMR solutions, for f, y, c I, c2. Knowledge of Trp orientations is important for understanding gramicidin action, and the above results (together) with those we are planning to obtain with commercially available 13C glycines and alanines) should together clearly indicate the utility of chemical shifts in structure studies, especially since the chemical shift is, in a sense, the most fundamental NMR property.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next generation bisphosphonates for chemo- and immuno-therapy
Next generation bisphosphonates for chemo- and immuno-therapy
Next generation bisphosphonates for chemo- and immuno-therapy
Next generation bisphosphonates for chemo- and immuno-therapy
海外基金